We endeavour to resolve some of the confusion surrounding the (mis) use of the term ‘colloidal silver’, particularly in a pharmaceutical context. It is proposed that, wherever possible, the term ‘colloidal silver’ be replaced by a clearer descriptor indicating a silver formulation’s composition and function, particularly when used either to help treat infections and/or to stimulate healing (as in restorative medicine).
|Title :||‘Colloidal Silver’: Recommendations to Remove This Misleading Term for Describing Nanoparticulate Silver Antimicrobial Agents|
|Published :||25 April 2017|
|Author:||Hans Laroo and Michael Whitehouse|